<DOC>
	<DOCNO>NCT02046564</DOCNO>
	<brief_summary>To evaluate efficacy safety ASC-01 ( aripiprazole/sertraline combination ) compare sertraline monotherapy patient major depressive disorder respond incompletely sertraline monotherapy .</brief_summary>
	<brief_title>Assess Efficacy Safety ASC-01 Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Patients either inpatient outpatient . Patients able understand necessary information give consent undergo examination , observation , evaluation specify clinical protocol , able give write consent base full understanding trial . Patients give diagnosis `` Major Depressive Disorder , Single Episode '' `` Major Depressive Disorder , Recurrent '' accord DSM5 current episode major depression continue least 8 week Patients HAMD 17 total score 18 Screening Period evaluation Female patient childbearing potential wish become pregnant trial period within 4 week completion discontinuation trial Pregnant breastfeed female patient , female patient may pregnant Patients judge intolerant antidepressant ( include drug use current episode major depression ) base treatment history Patients electroconvulsive therapy Patients enrol clinical trial drug medical device within 1 month time informed consent Patients medical history suggest risk develop serious adverse event symptom may hinder efficacy/safety evaluation ( eg , symptoms fibromyalgia , premenstrual syndrome etc overlap depressive symptom ) Patients complication history diabetes mellitus , patient judge diabetic fasting blood glucose level ≥ 126 mg/dL 2hour glucose level 75g oral glucose tolerance test ( OGTT ) ≥ 200 mg/dL nonfasting blood glucose level ≥ 200 mg/dL HbA1c [ NGSP level ] ≥ 6.5 % Patients undergoing treatment thyroid disease ( except patient whose disease stabilize drug therapy 3 month long time informed consent ) Patients history neuroleptic malignant syndrome serotonin syndrome Patients history seizure disorder ( eg , epilepsy )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>